Hookipa Pharma Inc Expected To Post A Loss Of 28 Cents A Share: Earnings Preview

Hookipa Pharma

11/11/2022 16:02

* HOOKIPA Pharma Inc  HOOK.OQ   HOOK.O  is expected to show
a fall
in quarterly revenue when it reports  results on November 14. 
    * The New York City-based  company is expected to report  a
24.9% decrease in revenue to $2.908 million from $3.87 million a
year ago, according to the mean estimate from 6 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for HOOKIPA Pharma Inc
is for
a loss of 28 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for HOOKIPA
Pharma
Inc is $7​, above​ its last closing price of $1.26. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.36       -0.36      -0.23     Beat    36.1
 Mar. 31 2022  -0.24       -0.24      -0.40     Missed  -66.7
 Dec. 31 2021  -0.63       -0.58      -0.65     Missed  -12.3​
 Sep. 30 2021  -0.52       -0.52      -0.61     Missed  -16.6
 ​​Jun.        -0.53       -0.53      -0.52     Beat    1.6
 30 2021                                                
 Mar. 31 2021  -0.52       -0.53      -0.53     Met     0.6​
 Dec. 31 2020  -0.54       -0.58      -0.46     Beat    21.4
 Sep. 30 2020  -0.44       -0.43      -0.53     Missed  -22.8
 This summary was machine generated November 11 at 16:02 GMT. 
All figures in US dollars  unless otherwise stated